Gynecological Contraceptive Implant Market

The gynecological contraceptive implant market is evolving, shaped by access, reimbursement, and care delivery changes that require tactical, evidence-based decisions. Senior healthcare executives face a dynamic environment where innovation, policy, and operational realities collectively influence adoption and outcomes.

Market Snapshot: Growth Trajectory and Strategic Landscape

The gynecological contraceptive implant market grew from USD 450.94 million in 2025 to USD 475.52 million in 2026 and is projected to continue at a compound annual growth rate (CAGR) of 5.52%, reaching USD 657.19 million by 2032. This growth reflects increased recognition of long-acting reversible contraception (LARC) in modern women’s health. The sector’s influence extends across clinical effectiveness, care accessibility, and health system priorities.

Scope & Segmentation: Navigating Adoption Drivers and Market Realities

Product Types: Etonogestrel-based and levonorgestrel-based implants as well as other progestin alternatives.
Duration of Use: Options designed for multi-year contraceptive protection, typically ranging from three to five years.
End User Segments: Adolescents, adults, and postpartum women, each facing unique access considerations and influencing clinic workflow.
Distribution Channels: Hospital pharmacies, health systems, retail pharmacies, specialty distributors, and online platforms.
Care Settings: Hospitals, OB/GYN clinics, community health centers, ambulatory surgical centers, school-based clinics, and mobile health units.
Geographies: Americas, Europe, Middle East & Africa, Asia-Pacific—each marked by distinct policy, procurement, and infrastructure variables.

These segments drive operational, training, and adoption patterns, with emphasis on real-time access, training scalability, and the ability to align with local healthcare delivery norms. Technology advancements in inserter design, packaging, and digital support further influence differentiation, especially where procedural efficiency and patient education requirements are high.

Key Takeaways for Decision-Makers

Pathway integration, including same-day access and workflow redesign, is fundamental to meeting patient demand and reducing drop-off between counseling and insertion.
Adoption drivers extend beyond device efficacy; provider training, reimbursement clarity, and supply dependability play central roles in real-world implementation.
Expansion into non-traditional care settings, such as community clinics and mobile health programs, necessitates adaptable training, scalable materials, and field support as core extensions to the product.
Patient satisfaction relies heavily on clear counseling about side effects and the removal process, making continuation strategies and education materials essential for enduring uptake.
Real-world evidence collection, including study of discontinuation rates and healthcare utilization, is increasingly critical as reimbursement models link financing with outcomes and operational proof points.
Customized approaches for each region and population segment, backed by robust procurement models and culturally competent education, remain key to sustainable market access.

Tariff Impact: 2025 Implications for Cost and Sourcing

Anticipated United States tariff changes in 2025 are expected to amplify cost pressures, particularly by impacting component sourcing, packaging, and logistics. Manufacturers and distribution partners are revising risk management strategies by

Conducting detailed bill-of-materials mapping to identify inputs with highest volatility exposure.
Pursuing dual sourcing and qualifying alternative suppliers for resilience.
Re-examining contract terms, inventory strategies, and contingency plans to sustain point-of-care availability.

These shifts are pushing firms to focus on supplier qualification, inventory planning, and strategic investment in domestic or nearshore capacity, minimizing operational disruption amid policy uncertainty.

Methodology & Data Sources

This report combines stakeholder interviews—including clinicians, administrators, and supply chain participants—with validated secondary sources such as regulatory guidance, clinical literature, and public procurement data. Analyses use triangulation to confirm findings and connect operational, clinical, and strategic market factors for a comprehensive view.

Why This Report Matters

Delivers actionable insights into how structural changes, policy shifts, and channel dynamics impact adoption and competitive advantage.
Supports senior executives in contingency planning for tariffs, supply reliability, and operational risks that directly affect care delivery and patient outcomes.
Offers evidence-backed recommendations for program integration, equity-focused strategy, and pathway resilience in a changing healthcare landscape.

Conclusion

As the gynecological contraceptive implant market transitions toward a service-enabled, systems-based approach, decision-makers who prioritize pathway execution, real-world evidence, and resilient sourcing will secure enduring competitive advantage. These capabilities underpin sustainable access and high-impact patient care.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Gynecological Contraceptive Implant Market, by Product

8.1. Etonogestrel Implant
8.2. Levonorgestrel Implant

9. Gynecological Contraceptive Implant Market, by End User

9.1. Clinic
9.2. Hospital
9.2.1. Private Hospital
9.2.2. Public Hospital
9.3. Specialty Center

10. Gynecological Contraceptive Implant Market, by Distribution Channel

10.1. Offline
10.2. Online

11. Gynecological Contraceptive Implant Market, by Region

11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific

12. Gynecological Contraceptive Implant Market, by Group

12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO

13. Gynecological Contraceptive Implant Market, by Country

13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea

14. United States Gynecological Contraceptive Implant Market
15. China Gynecological Contraceptive Implant Market

16. Competitive Landscape

16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Actavis plc
16.6. Agile Therapeutics, Inc.
16.7. Allergan plc
16.8. Amgen Inc.
16.9. AstraZeneca PLC
16.10. Bayer AG
16.11. Bristol-Myers Squibb Company
16.12. Eli Lilly and Company
16.13. Evofem Biosciences, Inc.
16.14. Gilead Sciences, Inc.
16.15. HRA Pharma
16.16. Johnson & Johnson
16.17. Merck & Co., Inc.
16.18. Mylan N.V.
16.19. Novartis AG
16.20. Novo Nordisk A/S
16.21. Pfizer Inc.
16.22. Roche Holding AG
16.23. Sanofi S.A.
16.24. Sun Pharmaceutical Industries Ltd.
16.25. Takeda Pharmaceutical Company Limited
16.26. Teva Pharmaceutical Industries Ltd.
16.27. Warner Chilcott plc

List of Figures

FIGURE 1. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY ETONOGESTREL IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY ETONOGESTREL IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY ETONOGESTREL IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY LEVONORGESTREL IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY LEVONORGESTREL IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY LEVONORGESTREL IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY SPECIALTY CENTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY SPECIALTY CENTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY SPECIALTY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. AMERICAS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 35. AMERICAS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 36. AMERICAS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 37. AMERICAS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 38. AMERICAS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 39. NORTH AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. NORTH AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 41. NORTH AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 42. NORTH AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 43. NORTH AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 44. LATIN AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. LATIN AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 46. LATIN AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 47. LATIN AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 48. LATIN AMERICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 54. EUROPE GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. EUROPE GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 56. EUROPE GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. EUROPE GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 58. EUROPE GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 59. MIDDLE EAST GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. MIDDLE EAST GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 61. MIDDLE EAST GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. MIDDLE EAST GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 63. MIDDLE EAST GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 64. AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 66. AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 67. AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 68. AFRICA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. ASEAN GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. ASEAN GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 77. ASEAN GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. ASEAN GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 79. ASEAN GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 80. GCC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GCC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 82. GCC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. GCC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 84. GCC GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. EUROPEAN UNION GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. EUROPEAN UNION GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 87. EUROPEAN UNION GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. EUROPEAN UNION GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 89. EUROPEAN UNION GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. BRICS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. BRICS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 92. BRICS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. BRICS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 94. BRICS GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. G7 GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. G7 GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 97. G7 GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. G7 GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 99. G7 GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. NATO GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. NATO GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 102. NATO GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. NATO GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 104. NATO GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. UNITED STATES GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 107. UNITED STATES GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 108. UNITED STATES GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. UNITED STATES GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 110. UNITED STATES GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. CHINA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 112. CHINA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 113. CHINA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. CHINA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
TABLE 115. CHINA GYNECOLOGICAL CONTRACEPTIVE IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Gynecological Contraceptive Implant market report include:

Actavis plc
Agile Therapeutics, Inc.
Allergan plc
Amgen Inc.
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Eli Lilly and Company
Evofem Biosciences, Inc.
Gilead Sciences, Inc.
HRA Pharma
Johnson & Johnson
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Roche Holding AG
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Warner Chilcott plc

Table Information

Report Attribute	Details
No. of Pages	180
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 475.52 Million
Forecasted Market Value ( USD ) by 2032	$ 657.19 Million
Compound Annual Growth Rate	5.5%
Regions Covered	Global
No. of Companies Mentioned	24

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3436EUR$3,939USD£2,992GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3706EUR$4,249USD£3,228GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5024EUR$5,759USD£4,375GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6079EUR$6,969USD£5,294GBP

Gynecological Contraceptive Implant Market - Global Forecast 2026-2032

Market Snapshot: Growth Trajectory and Strategic Landscape

Scope & Segmentation: Navigating Adoption Drivers and Market Realities

Key Takeaways for Decision-Makers

Tariff Impact: 2025 Implications for Cost and Sourcing

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Growth Trajectory and Strategic Landscape

Scope & Segmentation: Navigating Adoption Drivers and Market Realities

Key Takeaways for Decision-Makers

Tariff Impact: 2025 Implications for Cost and Sourcing

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Gynecological Contraceptive Implant Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032

Hormonal Contraceptives Market Outlook 2025-2034: Market Share, and Growth Analysis

Hormonal Contraceptives Market - Global Forecast 2026-2032

Subdermal Contraceptive Implants Market - Global Strategic Business Report